Hosted on MSN16d
CDC investigating hospitalizations of five people who recently received chikungunya vaccineIn a notice posted Tuesday on a vaccine information page for health-care providers, the CDC said that the people, all 65 and older, were hospitalized for cardiac or neurologic events following ...
NEW YORK CITY, NY / ACCESS Newswire / March 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of ...
If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and older The European Commission (EC) will now review ...
IXCHIQ is a single-dose, live-attenuated vaccine indicated for active immunization against the chikungunya virus, and represents the first (and currently only) chikungunya vaccine. According to ...
Valneva has met its revenue growth target for 2024, fending off slower-than-expected sales for the chikungunya vaccine Ixchiq. The French vaccine specialist posted total revenues of €169.6m ($ ...
“Let’s not draw any conclusions yet. That’s why they’re doing the investigation.” The IXCHIQ vaccine, administered as a single-dose shot into the muscle, contains a live, weakened ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback